Ondas Holdings stock in focus after $1 billion premium stock-and-warrant sale

Ondas Holdings stock in focus after $1 billion premium stock-and-warrant sale

NEW YORK, Jan 10, 2026, 18:42 EST — Market closed.

  • Ondas shares dropped 2.3% on Friday following the announcement of a $1 billion stock-and-warrant offering
  • The deal carries a premium over the previous close, with closing anticipated near Jan. 12
  • Traders have their eyes on the U.S. CPI release set for Jan. 13, followed by Ondas management’s investor presentations from Jan. 14 to 16

Ondas Holdings Inc (ONDS) shares slid 2.3% to close at $13.69 on Friday, bouncing between $15.10 and $13.59 throughout the session as the market absorbed news of the company’s $1 billion financing deal.

The raise is sizable by Ondas’ standards. It gives the company new ammunition for deals and growth just as interest in defense and security-focused drone stocks heats up, though it also quickly boosts the potential share count.

The mix matters now, given the financing includes a heavy load of warrants—rights to purchase stock later at a set price—and management is set to unveil more details of its 2026 plan in the next few days. If that narrative falters, the stock could suffer.

Ondas priced a registered direct offering of 19 million common shares plus pre-funded warrants for up to 41.79 million shares. The deal also includes warrants allowing buyers to purchase two shares for each share equivalent sold. The combined price came in at $16.45 per share-plus-warrant, roughly 17.5% above the Jan. 8 closing price. The transaction is slated to close on or around Jan. 12. (Ondas Holdings Inc.)

The company said the common stock warrants have a $28 exercise price and will last seven years. If all are exercised for cash, Ondas could pull in roughly $3.4 billion, though it warned there’s no guarantee this will happen. Proceeds are targeted for corporate development and strategic growth efforts, such as acquisitions, joint ventures, and investments. Oppenheimer is serving as the lead placement agent. (Ondas Holdings)

A registered direct offering involves selling securities straight to an investor under a shelf registration already filed with the U.S. Securities and Exchange Commission. Pre-funded warrants come into play when buyers want nearly all the economic benefits of a share upfront but postpone full issuance, usually to navigate ownership caps.

In a separate regulatory filing, Ondas disclosed unaudited, preliminary financial data for Sentry CS Ltd, the Israeli counter-drone firm it bought in November. The filing reported Sentry’s projected 2024 sales at $11.35 million, with a net loss of $13.51 million, noting these figures await finalization through financial closing procedures.

Ondas offers autonomous systems and private wireless solutions via its business units, Ondas Autonomous Systems and Ondas Networks, according to its company profile. (Reuters)

The investor calendar is packed. Ondas announced that CEO Eric Brock will join Needham’s defense tech analyst Austin Bohlig for a fireside chat at 8:45 a.m. ET on Jan. 14, taking place during the Needham Growth Conference. (Ondas Holdings Inc.)

Ondas Holdings Inc. will hold a virtual investor day at 10:00 a.m. ET on Jan. 16, just two days from now. Management plans to deliver a financial update and outline their 2026 outlook, followed by a Q&A session. (Ondas Holdings Inc.)

Macro data remains a potential market mover. The U.S. CPI for December 2025 drops at 8:30 a.m. ET Tuesday, Jan. 13. The following day, Wednesday, Jan. 14, brings the November 2025 Producer Price Index, also at 8:30 a.m. ET. The Federal Reserve’s next policy meeting is set for Jan. 27–28.

Traders will closely watch if Ondas can stay above Friday’s $13.59 low and reclaim the $15 level it reached earlier that day. The stock closed at $13.69 on Friday, still under Thursday’s $14.01 finish—a mark many short-term traders see as a crucial threshold.

The downside is clear. Despite a headline premium, the deal brings significant dilution risk and a warrant overhang, while the stock’s recent volatility can work against shareholders when liquidity dries up. Execution risk is still on the table—investors will need to see concrete evidence that the cash converts into revenue without triggering further financings.

Monday marks the market’s first chance to gauge any follow-through once trading kicks back in, with the Jan. 12 close serving as the immediate checkpoint. The management events slated for Jan. 14–16 are set to drive the next wave of activity. Ondas hasn’t confirmed its next earnings date, but Zacks pins it around March 11. (Zacks)

Stock Market Today

  • Gilead Sciences priced for upside after 38.5% one-year gain, DCF signals undervaluation
    January 11, 2026, 11:55 AM EST. GILD traded near $121.10, up 0.6% in 30 days and 38.5% over the past year. The stock's longer-term returns-56.0% over three years and 131.7% over five-frame questions about risk and upside as investors reassess pipelines, approvals and competitive pressures in biopharma. A valuation check assigns Gilead Sciences a 5 out of 6 score, then three methods show divergent views. A two-stage free cash flow to equity model yields an intrinsic value around $274.50 per share, implying the stock is about 55.9% undervalued vs $121.10. The P/E stands at 18.53x, modest versus some biotech peers, underscoring how growth expectations and risk shape multiples. Overall, the model suggests meaningful upside from current levels.
Rubrik stock slips again after CFO sale filing — what to watch before Monday’s open
Previous Story

Rubrik stock slips again after CFO sale filing — what to watch before Monday’s open

Ford stock pulls back from rally as ‘eyes-off’ driving plan and Piper upgrade hit tape
Next Story

Ford stock pulls back from rally as ‘eyes-off’ driving plan and Piper upgrade hit tape

Go toTop